CLVT
Clarivate Plc
CLVT has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CLVT overall, supported by stronger fundamentals and stronger modeled upside.
CLVT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Weak |
CLVT's cash flow is currently healthy, but its revenue, profitability and balance sheet are under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CLVT PE Valuation
CLVT has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CLVT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CLVT's earnings and revenue to decline, though with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over CLVT on the outlook, with more favorable earnings and revenue expectations.
CLVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.62 | — |
| Q3 2026 | -$0.61 | -$0.04 |
| Q2 2026 | -$0.52 | +$0.10 |
| Q1 2026 | -$0.21 | +$0.76 |
| Q4 2025 | -$0.30 | +$0.66 |
| Q3 2025 | -$0.57 | +$1.41 |
| Q2 2025 | -$0.62 | +$1.28 |
| Q1 2025 | -$0.97 | +$0.68 |
| Q4 2024 | -$0.96 | +$0.51 |
CLVT is still losing money, but far less than before: $0.61 per share over the past year, against $6.35 at its worst in mid-2023.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CLVT in the latest year-over-year earnings comparison.
CLVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $481.6M | -23% |
| Q2 2026 | $587.3M | -5.5% |
| Q1 2026 | $585.5M | -1.4% |
| Q4 2025 | $617M | -6.9% |
| Q3 2025 | $623.1M | +0.1% |
| Q2 2025 | $621.4M | -4.4% |
| Q1 2025 | $593.7M | -4.4% |
| Q4 2024 | $663M | -3% |
CLVT's revenue has slid since its 2022 peak: $482M last quarter, down 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | +1.3 points |
| Q2 2026 | -34% | -35 points |
| Q1 2026 | 5.2% | +8.7 points |
| Q4 2025 | 6.7% | +16 points |
| Q3 2025 | 7.1% | +3.6 points |
| Q2 2025 | 1.1% | +38 points |
| Q1 2025 | -3.5% | -4.3 points |
| Q4 2024 | -9.4% | +106 points |
CLVT's operating margin was 8.3% last quarter, up 1.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CLVT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CLVT on profitability, with a higher operating margin.
CLVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $110.2M | -4.6% |
| Q2 2026 | $44M | -13% |
| Q1 2026 | $78.9M | -28% |
| Q4 2025 | $89.2M | +51% |
| Q3 2025 | $115.5M | -8.6% |
| Q2 2025 | $50.3M | -17% |
| Q1 2025 | $110.3M | -1.3% |
| Q4 2024 | $59.1M | -53% |
CLVT still generates free cash flow, though less than at its 2023 peak: $322M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over CLVT on cash flow, with more consistent year-over-year improvement.
CLVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +300K shares |
| 1 year | -4.3% | -28.6M shares |
| 3 years | -4.7% | -31.2M shares |
| 5 years | +4.7% | +28.6M shares |
| Available history | +86% | +297M shares |
CLVT has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $18.1M |
| Q4 2025 | $75M |
| Q3 2025 | $50M |
| Q2 2025 | $49.5M |
| Q1 2025 | $50M |
| Q4 2024 | $100M |
CLVT spent $93M buying back its own shares over the past year, down 63% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CLVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.1x | High |
| Q2 2026 | 6.0x | High |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 9.7x | High |
| Q4 2024 | 9.4x | High |
CLVT's net debt is about 6.1 years of its operating earnings (EBITDA), up from 5.7 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over CLVT on leverage, with a lower net debt burden relative to earnings.
CLVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.8 | Neutral |
| Stochastic | 66.9 | Neutral |
CLVT's weekly RSI is 54 (neutral) and its Stochastic is 67 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CLVT PE vs Technology Sector
| Metric | CLVT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLVT has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CLVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.85 | 24% above |
| 20 week MA | $1.99 | 16% above |
| 50 week MA | $2.38 | 3.4% below |
| 100 week MA | $3.29 | 30% below |
| 200 week MA | $5.46 | 58% below |
CLVT has stronger trend alignment. CLVT is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CLVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.0 | $30.1 | +77% |
| 2021 | $30.1 | $24.7 | -18% |
| 2022 | $24.7 | $8.16 | -67% |
| 2023 | $8.16 | $9.26 | +13% |
| 2024 | $9.26 | $5.12 | -45% |
| 2025 | $5.12 | $3.50 | -32% |
| 2026 YTD | $3.50 | $2.30 | -34% |
CLVT has finished lower in four of the last six years. It's down 34% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CLVT on returns for 2026, with the stronger performance.